Islet cell
Showing 1 - 25 of >10,000
Islet Autotransplantation in Pancreatic Surgery
Recruiting
- Diabetes
-
Milan, ItalyOspedale San Raffaele (OSR)
Dec 1, 2022
Inflammation, Immunity, Islet Cell and Intestinal Hormone
Completed
- Obesity
- +9 more
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Sep 12, 2022
Benign Pancreatic Tumor, Chronic Pancreatitis, Recurrent Acute Pancreatitis Trial in Portland (Pancreatectomy, Quality-of-Life
Not yet recruiting
- Benign Pancreatic Neoplasm
- +2 more
- Pancreatectomy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 7, 2022
Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)
Completed
- Pancreatic Neuroendocrine Tumor G2
- Octreotide LAR
- (no location specified)
Oct 17, 2023
Development of New Personalised 3D Preclinical Models of
Recruiting
- Pancreatic Neuroendocrine Tumor
-
Milan, MI, ItalyIRCCS San Raffele Institute
Nov 2, 2023
Type 1 Diabetes Trial in Edmonton (Islet isolation using BMX-010)
Completed
- Type 1 Diabetes
- Islet isolation using BMX-010
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 5, 2022
Type 1 Diabetes Trial in Duarte (Allogenic Human Islet Cells, Immunosuppressive Agents, Gastrin 17)
Recruiting
- Type 1 Diabetes Mellitus
- Allogenic Human Islet Cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Diabetes, Type I Trial in Miami (islets)
Active, not recruiting
- Diabetes Mellitus, Type I
-
Miami, FloridaUniversity of Miami, Diabetes Research Institute
Mar 1, 2022
Multi-dimensional Fragmentomic Assay for Early Detection of
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Fragmentomic profiles of plasma cfDNA
- (no location specified)
Apr 27, 2023
Type1diabetes, Hypoglycemia, Hypoglycemia Unawareness Trial in Philadelphia (Phentolamine, Propranolol, Placebo)
Active, not recruiting
- Type1diabetes
- +3 more
- Phentolamine
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania - Institute for Diabetes, Obesity and
Mar 3, 2022
Nephrologic Prognosis 10 Years After Diabetes Cell Therapy
Completed
- Islet Transplantation
- islet transplanted
- non islet transplanted
-
Lille, FranceLille University Hospital
Apr 28, 2022
Chronic Pancreatitis, Diabetes, Islet Cell Transplantation Trial in Minneapolis (Intrahepatic islets and islets in the omental
Recruiting
- Chronic Pancreatitis
- +2 more
- Intrahepatic islets and islets in the omental pouch
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 16, 2022
Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived
Not yet recruiting
- Islet Transplantation
- Infusion of recipient T regulatory cell
- Infusion of concomitant Donor Derived Vertebral Bone Marrow
-
Palo Alto, CaliforniaStanford University
Jul 25, 2023
Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,
Not yet recruiting
- Metastatic Pancreatic Neuroendocrine Tumor
- Unresectable Pancreatic Neuroendocrine Carcinoma
- Lutetium Lu 177 Dotatate
- +4 more
- (no location specified)
Feb 10, 2022
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer
Recruiting
- VHL Pancreatic Neuroendocrine Tumors
- +2 more
- 68-Gallium DOTATATE
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Type 1 Diabetes Trial in Edmonton (AT-1501)
Recruiting
- Type 1 Diabetes Mellitus
-
Edmonton, Alberta, CanadaUniversity of Alberta
Sep 2, 2021
Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)
Recruiting
- Pancreatic Neuroendocrine Tumor
- peptide receptor radionuclide therapy with Y-90-DOTATOC
-
Milano, Italy
- +1 more
Sep 30, 2022
Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning
Recruiting
- Nonfunctional Pancreatic Neuroendocrine Tumor
- +2 more
- EUS-guided ethanol ablation
- EUS-guided lauromacrogol ablation
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 30, 2022
Cause for Post-Transplant Diabetes Mellitus After Allogeneic
Recruiting
- Diabetes Mellitus
- Cancer
- Oral Glucose Tolerance Test (OGTT)
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 10, 2022
Diabetes type1 Trial (cePolytreg)
Not yet recruiting
- Diabetes type1
- cePolytreg
- (no location specified)
Jul 8, 2022
Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Pancreas Cancer
- cytoreductive surgery
- +2 more
-
Chicago, IllinoisThe University of Chicago
Nov 8, 2022
Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)
Recruiting
- Multiple Endocrine Neoplasia Type 1
- Pancreatic Neuroendocrine Tumor
- EUS-guided fine-needle injection
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 24, 2022
Genetic Predisposition Testing Program for Pancreatic
Not yet recruiting
- Pancreatic Neuroendocrine Neoplasm
- Hereditary Cancer Panel
-
Los Angeles, California
- +2 more
Feb 17, 2023
Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine
Not yet recruiting
- Digestive System Neuroendocrine Tumor G1
- +5 more
- Tumor Debulking
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 23, 2023